Jonathan M SpergelDivision of Allergy and Immunology, The Children’s Hospital of Philadelphia Department of Pediatrics, University of Pennsylvania School of MedicineAbstract: Atopic eczema is a common pediatric skin disorder. This review examines the use of pimecrolimus cream in the treatment of acute and chronic stages of the disease. The standard therapy is the treatment of acute flares with topical medications including pimecrolimus. The use of pimecrolimus cream for the first sign and symptoms of atopic eczema reduces the occurrence of flares as defined by the need for topical corticosteroids. The side effects of pimecrolimus cream are mild without any increase of infections or systemic immune suppression.Keywords: pimecrolimu...
Pimecrolimus is a calcineurin inhibitor developed for the topical therapy of inflammatory skin disea...
<em>The lecture highlights the modern approaches to the therapy for atopic dermatitis among children...
OBJECTIVE: Pimecrolimus cream (SDZ ASM 981), a nonsteroid inhibitor of inflammatory cytokines, is ef...
The object of the investigation was to estimate the basic therapy of atopic dermatitis (ad) in child...
In the article, the authors discuss the local treatment of atopic eczema. They give data from the se...
BACKGROUND: This report investigates the effect of pimecrolimus cream 1% (Elidel, Novartis pharma AG...
The main objective for treatment of atopic dermatitis is to achieve the full control. Despite the fa...
Pimecrolimus 1% cream is an effective, non-corticosteroid, topical antiinflammatory treatment for at...
Pimecrolimus 1% cream is an effective, non-corticosteroid, topical antiinflammatory treatment for at...
Background Pimecrolimus cream I% has been shown to effectively control atopic eczema (AE) when appli...
Background: Pimecrolimus cream (Elidel®, SDZ ASM 981), a non-steroid inhibitor of inflammatory cytok...
Objective: To evaluate the efficacy and safety of pimecrolimus cream 1 % in the treatment of AD in t...
To evaluate the efficacy and safety of pimecrolimus cream 1% in the treatment of AD in the pediatric...
the increase in other atopic disorders seen in children such as asthma.1,5-7 AD is closely linked to...
The article highlights the findings of the open surveying uncontrolled multicentric postmarketing re...
Pimecrolimus is a calcineurin inhibitor developed for the topical therapy of inflammatory skin disea...
<em>The lecture highlights the modern approaches to the therapy for atopic dermatitis among children...
OBJECTIVE: Pimecrolimus cream (SDZ ASM 981), a nonsteroid inhibitor of inflammatory cytokines, is ef...
The object of the investigation was to estimate the basic therapy of atopic dermatitis (ad) in child...
In the article, the authors discuss the local treatment of atopic eczema. They give data from the se...
BACKGROUND: This report investigates the effect of pimecrolimus cream 1% (Elidel, Novartis pharma AG...
The main objective for treatment of atopic dermatitis is to achieve the full control. Despite the fa...
Pimecrolimus 1% cream is an effective, non-corticosteroid, topical antiinflammatory treatment for at...
Pimecrolimus 1% cream is an effective, non-corticosteroid, topical antiinflammatory treatment for at...
Background Pimecrolimus cream I% has been shown to effectively control atopic eczema (AE) when appli...
Background: Pimecrolimus cream (Elidel®, SDZ ASM 981), a non-steroid inhibitor of inflammatory cytok...
Objective: To evaluate the efficacy and safety of pimecrolimus cream 1 % in the treatment of AD in t...
To evaluate the efficacy and safety of pimecrolimus cream 1% in the treatment of AD in the pediatric...
the increase in other atopic disorders seen in children such as asthma.1,5-7 AD is closely linked to...
The article highlights the findings of the open surveying uncontrolled multicentric postmarketing re...
Pimecrolimus is a calcineurin inhibitor developed for the topical therapy of inflammatory skin disea...
<em>The lecture highlights the modern approaches to the therapy for atopic dermatitis among children...
OBJECTIVE: Pimecrolimus cream (SDZ ASM 981), a nonsteroid inhibitor of inflammatory cytokines, is ef...